PD-L1 quantification across tumor types using the reverse phase protein microarray: implications for precision medicine

• Mariaelena Pierobon,
• Johann De Bono,
• Ruth Riisnaes,
• Giuseppe Giaccone,
• Matthew Blackburn,
• Lance Liotta,
• Vienna Ludovini,
• Neil J Shah,
• Giuseppina Improta,
• Antonella Ravaggi,
• Niven Mehra,
• Angelo Sidoni,
• Elisa Baldelli,
• K Alex Hodge,
• Guido Bellezza,
• Guido Gambara,
• Martina Mandarano,
• Chamodya Ruhunusiri,
• Bryant Dunetz,
• Maysa Abu-Khalaf,
• Julia Wulfkuhle,
• Rosa I Gallagher,
• Franco Odicino,
• Maria Isabella Sereni,
• Angela Zupa,
• Perry Demsko,
• Lucio Crino',
• Emanuel F Petricoin

Affiliations

Mariaelena Pierobon

Aff498 grid.213910.80000000119551644Georgetown Lombardi Comprehensive Cancer Center Washington DC USA

Johann De Bono

Institute of Cancer Research, London, UK

Ruth Riisnaes

Drug Development Unit, Royal Marsden Hospital/ Institute of Cancer Research, Sutton, UK

Giuseppe Giaccone

Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, District of Columbia, USA

Matthew Blackburn

2University of Liverpool

Lance Liotta

3George Mason University, Manassas, VA, USA

Vienna Ludovini

Molecular Biology Laboratory, Medical Oncology Division, Ospedale Santa Maria della Misericordia, Perugia, Umbria, Italy

Neil J Shah

Department of Medicine, Weill Cornell Medical College, New York, NY, USA

Giuseppina Improta

2Laboratory of Clinical Research and Advanced Diagnostics, IRCCS-CROB, Rionero in Vulture, Italy

Antonella Ravaggi

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Brescia, Italy;

Niven Mehra

4 Department of Medical Oncology, Radboudumc, Nijmegen, The Netherlands

Angelo Sidoni

University of Perugia Medical School, Perugia, Italy

Elisa Baldelli

Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, USA

K Alex Hodge

Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, USA

Guido Bellezza

Department of Experimental Medicine, Section of Anatomic Pathology and Histology, University of Perugia, Perugia, Italy

Guido Gambara

Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, USA

Martina Mandarano

Department of Experimental Medicine, Section of Anatomic Pathology and Histology, University of Perugia, Perugia, Italy

Chamodya Ruhunusiri

Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, USA

Bryant Dunetz

Side Out Foundation, Fairfax, Virginia, USA

Maysa Abu-Khalaf

Department of Medical Oncology, Sidney Kimmel Cancer Center at Jefferson Health, Thomas Jefferson University, Philadelphia, Pennsylvania, USA

Julia Wulfkuhle

Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, USA

Rosa I Gallagher

Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, USA

Franco Odicino

Angelo Nocivelli Institute of Molecular Medicine, Division of Gynecologic Oncology, University of Brescia and ASST Spedali Civili di Brescia, Brescia, Italy

Maria Isabella Sereni

Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, USA

Angela Zupa

Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, USA

Perry Demsko

Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, USA

Lucio Crino'

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy

Emanuel F Petricoin

Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia, USA